Key Facts

Invested since 2012
Based in Jena

About the company

JeNaCell produces biotechnologically generated nanocellulose (BNC) in an IP protected, continuous and automated production process: high quality innovative products for applications in medicine, cosmetics and more.

Do you want to

know more about this company?

JeNaCell in the news

zum Artikel

News

2 August 2021

Successful exit for High-Tech Gründerfonds – HTGF fund investor Evonik acquires biotech company JeNaCell

zum Artikel

Press

9 July 2015

Additional financing for JeNaCell: Investors once again back platform technology for the production of high-tech bio-material

zum Artikel

Press

12 October 2012

JeNaCell Receives Seed Financing from High-Tech Gründerfonds and STIFT